Position in DXCM
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,212
+$647 QoQ
Shares Held
18
+100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#926
of 966 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Derivatives in DXCM
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$546
PutShares
8
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026Quaker Wealth Management, LLC holds $117,722 across 14 Medical Devices names. DXCM ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
619 | $55,994 | |
| 2 | ABT |
Abbott Laboratories
|
499 | $45,279 | |
| 3 | DCTH |
Delcath Systems, Inc.
|
400 | $5,036 | |
| 4 | SYK |
Stryker Corp
|
11 | $3,463 | |
| 5 | STE |
STERIS plc
|
8 | $1,684 | |
| 6 | MDT |
Medtronic plc
|
17 | $1,329 | |
| 7 | DXCM |
Dexcom Inc
This page
|
18 | $1,212 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
15 | $960 |
All Filings in DXCM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,212 | 18 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $565 | 9 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $530 | 8 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $471 | 7 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $698 | 8 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $546 | 8 | Put | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||